As of 2026-03-15, the Relative Valuation of Harmony Biosciences Holdings Inc (HRMY) is 41.64 USD. This relative valuation is based on P/E multiples. With the latest stock price at 27.61 USD, the upside of Harmony Biosciences Holdings Inc based on Relative Valuation is 50.8%.
The range of the Relative Valuation is 23.69 - 57.63 USD.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 16.4x | 12.2x |
| Forward P/E multiples | 12.4x - 19.8x | 17.1x |
| Fair Price | 23.69 - 57.63 | 41.64 |
| Upside | -14.2% - 108.7% | 50.8% |
| Date | P/E |
| 2026-03-13 | 10.03 |
| 2026-03-12 | 10.09 |
| 2026-03-11 | 10.45 |
| 2026-03-10 | 10.43 |
| 2026-03-09 | 10.37 |
| 2026-03-06 | 10.28 |
| 2026-03-05 | 10.35 |
| 2026-03-04 | 10.36 |
| 2026-03-03 | 10.26 |
| 2026-03-02 | 10.49 |
| 2026-02-27 | 10.36 |
| 2026-02-26 | 10.54 |
| 2026-02-25 | 10.23 |
| 2026-02-24 | 10.23 |
| 2026-02-23 | 9.75 |
| 2026-02-20 | 10.58 |
| 2026-02-19 | 12.48 |
| 2026-02-18 | 12.81 |
| 2026-02-17 | 13.40 |
| 2026-02-13 | 13.07 |
| 2026-02-12 | 13.01 |
| 2026-02-11 | 13.28 |
| 2026-02-10 | 13.77 |
| 2026-02-09 | 13.46 |
| 2026-02-06 | 13.53 |
| 2026-02-05 | 13.22 |
| 2026-02-04 | 13.55 |
| 2026-02-03 | 13.60 |
| 2026-02-02 | 13.74 |
| 2026-01-30 | 13.26 |
| 2026-01-29 | 13.38 |
| 2026-01-28 | 13.37 |
| 2026-01-27 | 13.68 |
| 2026-01-26 | 13.56 |
| 2026-01-23 | 13.36 |
| 2026-01-22 | 13.34 |
| 2026-01-21 | 13.32 |
| 2026-01-20 | 13.03 |
| 2026-01-16 | 13.15 |
| 2026-01-15 | 13.22 |
| 2026-01-14 | 13.08 |
| 2026-01-13 | 12.98 |
| 2026-01-12 | 13.89 |
| 2026-01-09 | 13.99 |
| 2026-01-08 | 13.75 |
| 2026-01-07 | 13.63 |
| 2026-01-06 | 13.34 |
| 2026-01-05 | 13.34 |
| 2026-01-02 | 13.57 |
| 2025-12-31 | 13.58 |